NCT03883581 Impact of Nuedexta on Bulbar Physiology and Function in ALS Status COMPLETED Phase PHASE1/PHASE2
NCT03876002 Evaluation of Microglial Activation in ALS With [18F]PBR06 (Peripheral Benzodiazepine Receptor-06) PET Status COMPLETED Phase PHASE1
NCT03851302 Effects of Remote Ischemic Conditioning on Hand Use in Individuals With SCI and ALS Status COMPLETED Phase NA
NCT03843710 31P-MRS Imaging to Assess the Effects of CNM-Au8 on Impaired Neuronal Redox State in Amyotrophic Lateral Sclerosis (REPAIR-ALS) Status WITHDRAWN Phase PHASE2
NCT03836716 Arimoclomol in Amyotropic Lateral Sclerosis - Open Label Extension Trial Status TERMINATED Phase PHASE3
NCT03835507 Randomized, Double-blind, Safety and Efficacy of Recombinant Human Erythropoietin in Amyotrophic Lateral Sclerosis Status RECRUITING Phase PHASE1/PHASE2
NCT03806647 Development and Needs Assessment and Efficiency of Smart Communication System for Patients With ALS (Part 1) Status UNKNOWN Phase N/A
NCT03806634 Development and Needs Assessment and Efficiency of Smart Communication System for Patients With ALS (Part 2) Status UNKNOWN Phase N/A
NCT03793868 Perampanel Single Ascending Dose Transcranial Magnetic Stimulation Biomarker Study in Amyotrophic Lateral Sclerosis Status COMPLETED Phase EARLY_PHASE1
NCT03792490 Inhibition of Rho Kinase (ROCK) With Fasudil as Disease-modifying Treatment for ALS Status COMPLETED Phase PHASE2
NCT03766321 Fecal Microbiota Transplantation Effect on Amyotrophic Lateral Sclerosis Patients Status ACTIVE_NOT_RECRUITING Phase NA
NCT03757351 Study to Evaluate DNL747 in Subjects With Amyotrophic Lateral Sclerosis Status TERMINATED Phase PHASE1
NCT03705390 A Safety and Tolerability Study of ILB® in Patients With Amyotrophic Lateral Sclerosis (ALS) Status TERMINATED Phase PHASE2
NCT03694132 Brain Excitability and Connectivity in Sensory-motor Pathways in ALS Status COMPLETED Phase NA